BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gray SG. Emerging avenues in immunotherapy for the management of malignant pleural mesothelioma. BMC Pulm Med 2021;21:148. [PMID: 33952230 DOI: 10.1186/s12890-021-01513-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Kunishige M, Kondo Y, Kadota N, Okano Y, Machida H, Hatakeyama N, Hino H, Naruse K, Shinohara T, Sakiyama S, Takeuchi E. Favorable response to nivolumab in sarcomatoid malignant pleural mesothelioma: A case report. Current Problems in Cancer: Case Reports 2022;5:100138. [DOI: 10.1016/j.cpccr.2022.100138] [Reference Citation Analysis]
2 Baas P, Daumont MJ, Lacoin L, Penrod JR, Carroll R, Venkatesan S, Ubhi H, Calleja A, Snee M. Treatment patterns and outcomes for patients with malignant pleural mesothelioma in England in 2013-2017: A nationwide CAS registry analysis from the I-O Optimise initiative. Lung Cancer 2021;162:185-93. [PMID: 34823894 DOI: 10.1016/j.lungcan.2021.11.001] [Reference Citation Analysis]
3 Chen Z, Yang C, Guo Z, Song S, Gao Y, Wang D, Mao W, Liu J. A novel PDX modeling strategy and its application in metabolomics study for malignant pleural mesothelioma. BMC Cancer 2021;21:1235. [PMID: 34789172 DOI: 10.1186/s12885-021-08980-5] [Reference Citation Analysis]
4 Zucali PA, De Vincenzo F, Perrino M, Digiacomo N, Cordua N, D'Antonio F, Borea F, Fazio R, Pirozzi A, Santoro A. Advances in Drug Treatments for Mesothelioma. Expert Opin Pharmacother 2022. [PMID: 35508368 DOI: 10.1080/14656566.2022.2072211] [Reference Citation Analysis]
5 Lisini D, Lettieri S, Nava S, Accordino G, Frigerio S, Bortolotto C, Lancia A, Filippi AR, Agustoni F, Pandolfi L, Piloni D, Comoli P, Corsico AG, Stella GM. Local Therapies and Modulation of Tumor Surrounding Stroma in Malignant Pleural Mesothelioma: A Translational Approach. Int J Mol Sci 2021;22:9014. [PMID: 34445720 DOI: 10.3390/ijms22169014] [Reference Citation Analysis]
6 Lu C, Yang D, Klement JD, Colson YL, Oberlies NH, Pearce CJ, Colby AH, Grinstaff MW, Ding HF, Shi H, Liu K. G6PD functions as a metabolic checkpoint to regulate granzyme B expression in tumor-specific cytotoxic T lymphocytes. J Immunother Cancer 2022;10:e003543. [PMID: 35017152 DOI: 10.1136/jitc-2021-003543] [Reference Citation Analysis]
7 Oddone E, Bollon J, Nava CR, Consonni D, Marinaccio A, Magnani C, Gasparrini A, Barone-Adesi F. Effect of Asbestos Consumption on Malignant Pleural Mesothelioma in Italy: Forecasts of Mortality up to 2040. Cancers (Basel) 2021;13:3338. [PMID: 34283067 DOI: 10.3390/cancers13133338] [Reference Citation Analysis]